Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
This trial includes two types of participants — patients and healthcare/industry stakeholders. Different parts of the trial have slightly different requirements.
Patients (across various parts of the trial):
- People aged 18 or older who have been diagnosed with a specific type of lung cancer called primary invasive adenocarcinoma, confirmed during surgery through a tissue sample analysis
- Depending on which part of the trial a patient is being considered for, they may or may not have already made a decision about whether to have molecular testing (genetic testing related to their lung cancer) — the trial site can clarify which applies
Healthcare professionals and other stakeholders (such as surgeons, nurses, hospital administrators, insurance company staff, and molecular testing company staff):
- People aged 18 or older who have at least 2 years of relevant work experience
- Surgeons and molecular testing company staff who have previous experience discussing lung cancer molecular testing with patients
- Nurses, hospital administrators, and insurance company staff who have a working understanding of how medical decisions are made
- For one part of the trial, clinicians must also be willing to take part voluntarily
Who may not be able to join:
- People who are unable to understand the content of the research
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The DA_LCMT 3.0
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.